DRG Instruments GmbH

DRG Instruments GmbH specializes in in-vitro diagnostic (IVD) reagents. These include systems like the DxDATA, which helps manage laboratory data, the Fecal Extraction System 2.6 for preparing fecal samples, and the Aldosterone Reagent Set Urine for hormone testing. Their products are designed to support immunoassays—such as ELISAs and chemiluminescent assays—used in areas like diabetes diagnosis, endocrinology, prenatal/neonatal monitoring, and thyroid function analysis.

DRG Instruments GmbH is headquartered in Marburg, Germany, which means its devices are subject to EU regulatory requirements. Since they are classified as EU Class A devices, they must comply with EU IVDR (In Vitro Diagnostic Regulation) rules, including mandatory registration in EUDAMED, the EU’s medical device database. This classification applies based on their intended use and risk profile, not the company itself.

Yes, DRG Instruments GmbH’s devices are listed in EUDAMED, the official EU database for medical devices. This registry ensures transparency about authorized products under the EU’s regulatory framework. Listing in EUDAMED confirms compliance with EU IVDR requirements, but it does not imply approval—only that the devices meet necessary regulatory criteria for market placement.

DRG Instruments GmbH’s devices fall under EU Class A classification. This classification is determined by their intended use and risk level, with Class A representing the lowest risk category for IVDs. The classification ensures appropriate regulatory oversight while minimizing burdens for low-risk products, such as certain reagents and sample preparation systems, without implying any approval status for the company itself.